Natural Alternatives International Stock News

NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Natural Alternatives International, Inc. ("NAI" or the "Company") (NASDAQ: NAII).

NEW YORK , Aug. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Natural Alternatives International, Inc. ("NAI" or the "Company") (NASDAQ: NAII).  Such in

CARLSBAD, Calif. , Aug. 16, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplement

CARLSBAD, Calif. , July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplemen

NAII is a contract manufacturer of nutritional supplements, including its own brand of beta-alanine. The company has generated low and inconsistent profits, caused by a weak competitive position, coup

With skyrocketing prices these days, we could all use a pick-me-up, which brings us to the best stocks under $15 to buy for 2023. For about the price of lunch in the current monetary paradigm, astute

If you're wondering if any objectively solid opportunities exist among the so-called best stocks under $15 to buy now, you might be pleasantly surprised. To be sure, merely acquiring publicly traded c

Natural Alternatives International <> authorizes a $3M increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $18M

Natural Alternatives International (NAI) adds $3M to its stock repurchase plan bringing the total plan authorized repurchase amount to $18M.The Company has purchased 1.9M shares

Natural Alternatives International, Inc. (NASDAQ:NAII)s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.86 and traded as low as $12.37. Natural Alternatives International shares last traded at $12.50, with a volume of 22,562 shares changing hands. The firm has a market cap []

Natural Alternatives International (NASDAQ: NAII) is one of 43 public companies in the Medicinals & botanicals industry, but how does it weigh in compared to its competitors? We will compare Natural Alternatives International to similar businesses based on the strength of its earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends. Risk and Volatility [] The post Critical Comparison: Natural Alternatives International (NAII) & Its Rivals appeared first on ETF Daily News .

Bon Natural Life (NYSE:BON) and Natural Alternatives International (NASDAQ:NAII) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk. Analyst Ratings This is a summary of current recommendations and price targets []

Natural Alternatives International (NASDAQ: NAII) is one of 43 public companies in the Medicinals & botanicals industry, but how does it contrast to its peers? We will compare Natural Alternatives International to similar companies based on the strength of its analyst recommendations, institutional ownership, valuation, risk, dividends, profitability and earnings. Analyst Recommendations This is a []

Natural Alternatives International (NASDAQ: NAII) is one of 43 public companies in the Medicinals & botanicals industry, but how does it weigh in compared to its competitors? We will compare Natural Alternatives International to similar businesses based on the strength of its dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability. Profitability This table []

Geode Capital Management LLC increased its stake in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 15.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,627 shares of the companys stock after buying an additional 4,517 shares during the quarter. []